register

News & Trends - MedTech & Diagnostics

Medical device costs go down as insurer profits go up

Health Industry Hub | August 21, 2019 |

According to Medical Technology Association of Australia (MTAA), Private Healthcare Australia’s response to yesterday’s APRA data, suggesting that the medical devices industry is ‘driving sales volume’ in response to government reforms, is factually incorrect.

According to the APRA data, despite an 8.6% increase in volume, an 8.5% drop in average benefit level has meant that insurers have paid a total of $13 million less for medical devices over the last financial year.

“The medical devices industry has made the only direct contribution to keeping the cost of private health insurance down, delivering the lowest premium increase in 18 years,” said Ian Burgess, CEO of the Medical Technology Association of Australia (MTAA).

“The cost reductions are a direct result of the $1.1 billion dollars in cuts delivered by MTAA through the Agreement and demonstrate MTAA’s active contribution to the affordability of healthcare in Australia,” Mr Burgess said.

Meanwhile, insurer profits continue to increase, with NIB reporting a 9.2 per cent increase in annual profit yesterday to $201.8 million, with a share price increase of 31 per cent over the past six months, and Medibank Private’s share price up 16 per cent.

“After tax profits for insurers are up 15% over the past three years as affordability for ordinary Australian families goes down,” Mr Burgess said.

“The suggestion that an increase in use of medical devices by privately insured patients is somehow a negative is a clear demonstration that the private health insurers have lost focus on consumers.”

Volume increases are being driven by an ageing population, an increase in chronic disease and the growing demand for new treatments due to the benefits provided by medical devices.

“Patient and clinician choice is a key part of the value proposition of private health insurance, one that risks being eroded by the false claims made by insurers about the cost of devices,” said Mr Burgess.

“The medical technology industry believes access to a full range of medical technology is one of the key benefits of having private health insurance and we’re committed to helping ensure all Australians lead healthier and more productive lives,” Mr Burgess concluded.

You may also like Zimmer Biomet’s innovative treatment for young patients with scoliosis


Digital & Innovation

Medical drone to reduce health equity gaps in rural and remote Australia

Medical drone to reduce health equity gaps in rural and remote Australia

Health Industry Hub | April 24, 2024 |

A specialised medical drone which increases accessibility to essential health services such as pathology, medicines, and telehealth services in rural […]

More


News & Trends - Pharmaceuticals

We’ve spent more on healthcare, but it’s been worth it

We’ve spent more on healthcare, but it’s been worth it

Health Industry Hub | April 24, 2024 |

Healthcare expenditure is surging, with Australia now allocating approximately one-tenth of its budget to this sector. This financial uptick prompts […]

More


News & Trends - Pharmaceuticals

New partnership to raise the bar in precision cancer care in Queensland

New partnership to raise the bar in precision oncology in Queensland

Health Industry Hub | April 24, 2024 |

Pharma News: The Australian Translational Genomics Centre (ATGC) is teaming up with non-profit research organisation Omico and the PrOSPeCT program […]

More


News & Trends - Biotechnology

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

Health Industry Hub | April 23, 2024 |

Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]

More


This content is copyright protected. Please subscribe to gain access.